Udayan Guha
Equibles does not estimate personal net worth.
Get an email with a short summary when NextCure, Inc. publishes a filing, an earnings call transcript or a press release.
Get NXTC alertsAbout Udayan Guha
The proxy statement of NextCure, Inc. reports total compensation of $639,239 for Udayan Guha in fiscal 2025, including a base salary of $474,192. NextCure, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NextCure, Inc. includes Michael Richman (CEO), Steven P. Cobourn (CFO), Timothy Mayer (COO) and 5 others.
Affiliation history
-
NextCure, Inc. (NXTC)
Proxy statement
CurrentStart not stated–present
Last confirmed April 24, 2026
Company network
Leadership on record at NextCure, Inc.
- Michael Richman CEO
- Steven P. Cobourn CFO
- Timothy Mayer COO
- Kevin G. Shaw General Counsel
- Anne Borgman Board Member
- Anne Borgman, M.D. Board Member
- Ellen Feigal Board Member
- John G. Houston, PH.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | NextCure, Inc. (NXTC) | M.D., Ph.D. Chief Medical Officer | $474,192 | $639,239 |
Recent activity
No call appearances or filed executive changes recorded yet.